Also trades as: TDSGF (OTC) · $vol 0M
TELO.V TSXV
Telo Genomics Corp.
1W: +71.4%
1M: +50.0%
3M: +33.3%
YTD: +50.0%
1Y: -25.0%
3Y: -78.6%
5Y: -87.1%
C$0.06 ($0.04)
+0.01 (+10.00%)
Weekly Expected Move ±26.5%
C$0
C$0
C$0
C$0
C$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$14K
+63.4% ▲
Operating Income
-$3M
+0.6% ▲
Net Income
-$3M
-0.2% ▼
EPS (Diluted)
$-0.03
+18.4% ▲
EBITDA
-$3M
-0.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $62K | $57K | $33K | $40K | $14K |
| Gross Profit | -$62K | -$57K | -$33K | -$40K | -$14K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $604K | $1M | $1M | $1M | $1M |
| SG&A Expenses | $653K | $987K | $1M | $1M | $1M |
| Operating Expenses | $1M | $2M | $3M | $3M | $3M |
| Operating Income | -$1M | -$2M | -$3M | -$3M | -$3M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $5K | $5K | $5K | $5K |
| Income Before Tax | -$1M | -$2M | -$3M | -$3M | -$3M |
| Tax Expense | $0 | $0 | $0 | $10K | $0 |
| Net Income | -$1M | -$2M | -$3M | -$3M | -$3M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.02 | $-0.04 | $-0.05 | $-0.04 | $-0.03 |
| EBITDA | -$1M | -$2M | -$3M | -$3M | -$3M |
| Shares Outstanding | 47M | 59M | 60M | 71M | 88M |